Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRTI International
About this trial
The objective of this study is to develop and pilot a program designed to improve mental health outcomes and reduce suicide risk during the transition from military to civilian life. It is hypothesized that the Transition Health and Resilience through Valued Experiences (THRiVE) program, to be developed as part of this study, will meet participant recruitment, retention, and satisfaction benchmarks (primary outcomes) and show positive preliminary effects on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes (secondary outcomes).
The specific aims of this study are to:
1. Develop a small-group, peer-led, cross-cutting prevention program for newly separated veterans (NSVs) called THRiVE and 2. Evaluate the feasibility, acceptability, and preliminary effects of the THRiVE program on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes.
Up to 40 NSVs participating in this Stage 1 pilot study will complete validated self-report measures at baseline, immediately after completing the THRiVE program (post-THRiVE), and 3 months after completing the THRiVE program (follow-up). The duration of a participant's time in the study is anticipated to be 5 months.
Eligibility criteria
Qualifiers
Be either (a) a United States military veteran who separated no more than 12 months prior to study enrollment or (b) a United States transitioning service member on terminal leave
Be at least 18 years old
Have access to the internet; a desktop computer, laptop, tablet, or other "smart" device with video camera, speakers, and microphone; and a private place from which to attend THRiVE sessions
Reside and complete all study activities within the United States
Disqualifiers
Endorse lifetime manic, hypomanic, or psychotic episodes
Meet Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for current severe alcohol use disorder or substance use disorder (except for tobacco use disorder, which will not be exclusionary)
Screen positive for moderate or high acute risk for suicide
Screen positive for more than minimal risk for other-directed violence
Trial design
Treatments tested in this trial
- Transition Health and Resilience through Valued Experiences (THRiVE) Program
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
RTI International
Lead sponsor
U.S. Army Medical Research Acquisition Activity
Collaborator
Source ClinicalTrials.gov